2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 21:25, 2 December 2023
, 2 December 2023→Potential Benefits
| Line 124: | Line 124: | ||
| style="vertical-align:top; border:none;" | <br>[[File:NMN NAD+ Mice.png|frameless|100px]] | | style="vertical-align:top; border:none;" | <br>[[File:NMN NAD+ Mice.png|frameless|100px]] | ||
| style="vertical-align:top; border-left: none;" | | | style="vertical-align:top; border-left: none;" | | ||
* '''Brain''': improved brain function, protected from neurodegeneration{{pmid|27130898}}{{pmid|35057482}}{{pmid|35593333}}{{pmid|31678348}}{{pmid|27425894}}, enhanced new myelin generation | * '''Brain''': improved brain function, protected from neurodegeneration{{pmid|27130898}}{{pmid|35057482}}{{pmid|35593333}}{{pmid|31678348}}{{pmid|27425894}}, enhanced new myelin generation{{pmid|35264567}} | ||
* '''Lung''': prevented pulmonary fibrosis, improved respiratory system function{{pmid|34766147}} | * '''Lung''': prevented pulmonary fibrosis, improved respiratory system function{{pmid|34766147}} | ||
* '''Liver''': improved liver function, reduced hepatic steatosis, increased capacity to regenerate{{pmid|35699728}}{{pmid|30185676}} | * '''Liver''': improved liver function, reduced hepatic steatosis, increased capacity to regenerate{{pmid|35699728}}{{pmid|30185676}} | ||